| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KROS | Keros Therapeutics, Inc. | Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | Nov 29, 2022 | Option Exercise | $0.00010 | 7,176 | 1 | 2,284,612 | Nov 30, 2022, 04:42 PM | |
| KROS | Keros Therapeutics, Inc. | Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | Nov 17, 2020 | Buy | $50.00 | 60,000 | 3,000,000 | 2,288,151 | Nov 19, 2020, 04:38 PM | |
| KROS | Keros Therapeutics, Inc. | Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | Apr 13, 2020 | Buy | $16.00 | 437,499 | 6,999,984 | 2,261,517 | Apr 13, 2020, 05:18 PM | |
| ETNB | 89bio, Inc. | Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | Nov 11, 2019 | Buy | $16.00 | 250,000 | 4,000,000 | 250,000 | Nov 13, 2019, 07:10 PM | |
| ELOX | Eloxx Pharmaceuticals, Inc. | Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | Jun 24, 2019 | Buy | $9.00 | 200,000 | 1,800,000 | 1,049,310 | Jun 26, 2019, 04:44 PM | |
| ELOX | Eloxx Pharmaceuticals, Inc. | Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | Apr 30, 2018 | Buy | $9.75 | 350,000 | 3,412,500 | 962,504 | May 01, 2018, 04:37 PM | |
| ELOX | Eloxx Pharmaceuticals, Inc. | Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | Mar 21, 2018 | Buy | $7.55 | 6,600 | 49,830 | 786,919 | Mar 23, 2018, 04:16 PM | |
| ELOX | Eloxx Pharmaceuticals, Inc. | Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | Mar 22, 2018 | Buy | $8.00 | 6,000 | 48,000 | 789,878 | Mar 23, 2018, 04:16 PM |
Menu